[18] [19] Important safety considerations include: Increased risk of hypoglycaemia when combined with insulin or sulfonylureas GLP-1 receptor agonists should not be used in combination with DPP-4 inhibitors [15] [18] These medications are not recommended during pregnancy or breastfeeding You should contact your GP if you experience: Persistent symptoms of hyperglycaemia (excessive thirst, frequent urination, unexplained weight loss) despite lifestyle modifications Difficulty managing your weight despite sustained efforts with diet and exercise Symptoms suggesting complications of diabetes or metabolic syndrome Severe or persistent gastrointestinal symptoms if already taking GLP-1 medications Seek urgent medical attention if you develop severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis, or right-sided abdominal pain or yellowing of the skin/eyes which could suggest gallbladder problems
Slowed gastric emptying: By delaying stomach emptying, GLP-1 RAs increase feelings of fullness and reduce meal size
Cost savings: Investing in our program can reduce long-term healthcare costs by preventing and managing chronic conditions associated with obesity
Properly shipped lyophilized peptide should arrive in a sealed vial with an intact flip-top cap, include an ice pack or insulated packaging for temperature control, have a clear label with batch number matching the COA, and show a white or off-white lyophilized cake or powder in the vial
Aayushi Pratap: Im a business reporter for C&EN
Nausea Vomiting Diarrhea Stomach pain Headache What is Mounjaro
